Member Login
  1. Stocks
    2. /
  2. GSK (LSE: GSK)
    3. /

LSE:GSK (GSK)

About GSK

GlaxoSmithKline is one of the worlds leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

  • Should you invest £1,000 in Gsk right now?

    When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets.

    And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Gsk made the list?

    See the 6 stocks

    • GSK (LSE: GSK) Latest News

    Investing Articles

    Should I buy GSK shares at £15?

    | Ben McPoland

    GSK shares are trading cheaply and offering potential passive income. So is this FTSE 100 stock a no-brainer buy for…

    Read more »

    A graph made of neon tubes in a room
    Investing Articles

    Is magic suddenly happening to the dirt cheap GSK share price?

    | Harvey Jones

    Harvey Jones has spotted signs of life in the GSK share price. Which is a relief after its recent troubles,…

    Read more »

    Investing Articles

    2 FTSE 100 stocks that investors should consider for income

    | Ken Hall

    Our writer Ken Hall evaluates two defensive dividend payers in the FTSE 100 that he thinks investors should consider buying…

    Read more »

    Calendar showing the date of 5th April on desk in a house
    Investing Articles

    3 steps to safeguard a Stocks and Shares ISA in 2025

    | Mark Hartley

    This year's gearing up to be a wild ride for stocks and shares so investors should consider a careful approach…

    Read more »

    Arrow symbol glowing amid black arrow symbols on black background.
    Investing Articles

    Down 21% from May despite excellent Q4 2024 results, is GSK’s share price an irresistible bargain to me now?

    | Simon Watkins

    GSK’s share price has fallen a long way on a combination of factors, but do its recent strong results leave…

    Read more »

    Investing Articles

    Billionaire’s hedge fund bets big against the GSK share price!

    | Cliff D'Arcy

    After years of limping along, the GSK share price has leapt 11% in one month. But one of America's richest…

    Read more »

    Investing Articles

    Here’s the dividend forecast for GSK shares through to 2026!

    | Royston Wild

    City brokers expect dividends on GSK shares will keep marching higher. Is the FTSE 100 share a top passive income…

    Read more »

    Investing Articles

    Down 15% and with a P/E below 9! Is the GSK share price still in deep value territory?

    | Harvey Jones

    Harvey Jones has something to celebrate after a positive set of results boosted the GSK share price after a disappointing…

    Read more »

    A GlaxoSmithKline scientist uses a microscope
    Investing Articles

    The GSK share price jumps 6% on positive FY 2024 results. Is it a stock to consider now?

    | Mark Hartley

    Mark Hartley weighs up the growing potential in GSK as its share price makes rare gains following a promising set…

    Read more »

    Man smiling and working on laptop
    Investing Articles

    GSK shares leap 5% as results top forecasts and guidance is upgraded! Can they keep rising?

    | Royston Wild

    Strong full-year trading and an improving outlook have propelled GSK's share price higher, as Royston Wild explains.

    Read more »

    Investing Articles

    Is it game over for the GSK share price?

    | Harvey Jones

    Harvey Jones isn't having much fun playing the GSK share price game. The FTSE 100 pharmaceutical stock must work hard…

    Read more »

    Investing Articles

    Down 16% and 18% – are my 2 biggest FTSE 100 losers about to rally hard?

    | Harvey Jones

    Two FTSE 100 stocks in Harvey Jones' portfolio have suffered double-digit losses. He's standing by them for now, but he's…

    Read more »